Proton Therapy Market report is segmented on product type, end user, application and by regional & country level. Based upon product type, proton therapy market is segmented into single room system and multi room system. On the basis of end user market is segmented into specialty clinics, hospitals, and ambulatory surgery centers. Based upon application, proton therapy market is classified into breast cancer, prostate cancer, brain cancer, lung cancer, and others.
Proton Therapy Market is valued at USD 1263.9 Million in 2018 and expected to reach USD 3341.5 Million By 2025 with CAGR of 14.9% over the forecast period.
Proton therapy is a radiation technique which is used for the treatment of cancer. Proton are charged particles and these particles are accelerates and target the tumor or cancer cells in the form of beam can damage the cancer cell and led to the death of cancer cell. Proton therapy is a costly treatment and requires a lot of setup such as electromagnets, accelerator, nozzle gantry and others. Photon therapy offers various advantages over conventional method such as improved efficiency and limited side effects. It is a non-invasive, painless treatment which helps to maintain the quality of life.
The regions covered in this Proton Therapy market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Proton Therapy market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Some major key players for Proton Therapy market are Mevion Medical Systems, Inc., ProTom International, Inc., IBA Worldwide, Hitachi, Ltd., Varian Medical Systems, Inc., and Mitsubishi Electric Corporation among others.
Increased prevalence of cancer and favorable reimbursement policies is the key factor which helps Proton Therapy Market to grow.
There has been tremendous increase in the prevalence of cancer due to the increased consumption of tobacco and smoking which may lead to mouth cancer, lung cancer and others. As per Cancer research UK report, there were around 17 million new cases of cancer has been reported in 2018 and by the end of 2040 the estimated cancer cases will be 27.5 million. As the prevalence of cancer has been increased there has also been change in the reimbursement policies and the government initiatives to provide better treatment which is expected to drive the growth of proton therapy market. Moreover, increasing public awareness and increase in disposable income is also expected to drive the growth of proton therapy market. On the other hand technological advancement and research and development activities are expected to create various opportunities in the proton therapy market over the forecast period. However, high installation cost is expected to hinder the growth of proton therapy market in the near future.
North America is expected to dominate the Proton Therapy Market.
North America is expected represents the develop countries and holds the largest market share which was closely followed by Europe over the forecast period. The presence of develop healthcare infrastructure with modern technology, and increased adoption of advanced technology and treatment options coupled with high disposable income are expected to be major factors driving the growth of proton therapy market. Asia Pacific is expected to develop significantly over the forecast period and maintain its dominance in the near future owing to the presence of developing economies such as India, China and others. Moreover, increased prevalence of cancer, increased public awareness, favorable reimbursement policies and government initiatives are expected to further contribute the growth of proton therapy market over the forecast period. Middle East, Latin America and Africa is expected to develop at a considerable growth over the forecast period.
Key Benefits for Market Reports –
By Product Type
By End Users
By Regional & Country Analysis: